GCIA
BEAT

Gabelli & Co Investment Advisers’s BioTelemetry, Inc. BEAT Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-18,100
Closed -$1.3M – 534
2020
Q4 		$1.3M Buy
+18,100
New +$947K 0.2% 93

Other funds holding BEAT

LCM
Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Gabelli & Co Investment Advisers's BEAT Position: Q1 2021 in Review

Gabelli & Co Investment Advisers sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 18,100 shares — an estimated $1.3M sold.

Gabelli & Co Investment Advisers first reported a position in BEAT in Q4 2020 and held it in 1 quarter. The position peaked at $1.3M in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

  • Gabelli & Co Investment Advisers reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
  • Gabelli & Co Investment Advisers sold 18,100 BioTelemetry, Inc. shares in Q1 2021, an estimated $1.3M.
  • Gabelli & Co Investment Advisers first reported a position in BioTelemetry, Inc. in Q4 2020 and held it in 1 quarter.
  • Gabelli & Co Investment Advisers's BioTelemetry, Inc. position peaked at $1.3M in Q4 2020.
  • 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Gabelli & Co Investment Advisers's 13F filing for Q1 2021, filed 14 May 2021.